Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Pharmacol ; 47(6): 715-26, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17442681

RESUMO

The aim of this study was to determine the analgesic effect of acetaminophen compared to a combination of both caffeine and acetaminophen or caffeine alone using tonic and phasic pain stimulation. Twenty-four subjects were treated orally with 1000 mg acetaminophen, 130 mg caffeine, and a combination of both in a 4-way crossover, double-blind, placebo-controlled study. Pharmacokinetics and analgesic effects were assessed by means of an experimental pain model based on pain-related cortical potentials after phasic stimulation of the nasal mucosa with CO(2) and based on pain ratings after tonic stimulation with dry air. Analgesic effects of acetaminophen and acetaminophen plus caffeine but not caffeine alone caused a significant reduction of pain-related cortical potentials beginning 30 minutes after medication. The combination demonstrated an enhanced effect throughout the observation time up to 3 hours. Caffeine accelerated acetaminophen absorption, indicated by enhanced early AUCs. Significant analgesic effects of the combination on tonic pain ratings were found throughout the observation time as compared to acetaminophen and placebo. In this study, caffeine enhanced and prolonged the analgesic activity of acetaminophen.


Assuntos
Acetaminofen/farmacocinética , Acetaminofen/uso terapêutico , Analgésicos não Narcóticos/farmacocinética , Analgésicos não Narcóticos/uso terapêutico , Cafeína/farmacologia , Estimulantes do Sistema Nervoso Central/farmacologia , Dor/tratamento farmacológico , Adolescente , Adulto , Área Sob a Curva , Estudos Cross-Over , Método Duplo-Cego , Sinergismo Farmacológico , Feminino , Humanos , Absorção Intestinal , Masculino , Pessoa de Meia-Idade , Solubilidade
2.
Clin Ther ; 28(9): 1273-8, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17062300

RESUMO

OBJECTIVE: The aim of this study was to determine the time to onset of pain relief from a single dose of a tablet formulation of paracetamol (acetaminophen) containing sodium bicarbonate (PSC). METHODS: A single oral dose of PSC or placebo was randomly administered to patients with acute sore throat under double-blind conditions. Patients rated their pain relief using a conventional categorical relief scale every 5 minutes during the first hour postdose to determine the time to onset of pain relief. They continued evaluations of pain relief at less frequent intervals to 6 hours postdose to confirm the overall analgesia of PSC compared with placebo. To determine if food had any effect on the onset of action of PSC, time to onset of analgesia by PSC was compared between patients in the fed and fasted states. Patients were randomized 3:1 to PSC:placebo based on whether they had eaten food within 2 hours of baseline. Adverse events were recorded by questioning throughout the study period. RESULTS: A total of 241 patients were enrolled. Both treatment groups were well matched for age (mean, 20 years), sex (male:female ratio, approximately 1:1.5), sore throat duration (mean, 3 days) and severity (mean score, 8). PSC separated significantly from placebo beginning at 15 minutes postdose (P < or = 0.03). There was no difference for onset of analgesia between PSC in the fed and fasted states. PSC showed significantly greater total pain relief over 30 minutes, 1 hour, and 6 hours compared with placebo (all, P < 0.05). Both treatments were well tolerated and there were no serious adverse events. CONCLUSION: PSC was effective beginning 15 minutes postdose and well tolerated compared with placebo in this population of adults with acute onset of sore throat pain.


Assuntos
Acetaminofen/uso terapêutico , Analgesia/métodos , Analgésicos não Narcóticos/uso terapêutico , Dor/tratamento farmacológico , Faringite/tratamento farmacológico , Bicarbonato de Sódio/uso terapêutico , Acetaminofen/administração & dosagem , Doença Aguda , Administração Oral , Adulto , Analgésicos não Narcóticos/administração & dosagem , Método Duplo-Cego , Combinação de Medicamentos , Feminino , Seguimentos , Humanos , Masculino , Dor/etiologia , Dor/fisiopatologia , Medição da Dor , Faringite/complicações , Faringite/fisiopatologia , Bicarbonato de Sódio/administração & dosagem , Resultado do Tratamento
3.
Drug Dev Ind Pharm ; 31(6): 515-25, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16109624

RESUMO

The purpose of this investigation was to study the dissolution behavior of paracetamol and ibuprofen in the presence of a range of selected potential excipients. First, a pH-solubility profile was generated for both drugs, and the effect of changing hydrodynamic conditions on the intrinsic dissolution rate was investigated. It was established that both drugs dissolved according to the diffusion-layer model. Paracetamol solubility (approximately 20.3 mg mL(-1)) did not vary from pH 1.2-8.0, corresponding to the in vivo range in the gastrointestinal tract. Ibuprofen had an intrinsic solubility of approximately 0.06 mg mL(-1), and pK(a) was calculated as 4.4. Second, the effects of selected potential excipients (lactose, potassium bicarbonate, sodium bicarbonate, sodium chloride, and tartaric acid) were evaluated by measuring the effect of the inclusion of each additive in the dissolution medium on drug solubility, drug intrinsic dissolution rate, and solution viscosity. The results were evaluated using the diffusion-layer model, and it was determined that for paracetamol, the collected data fitted the model for all the excipients studied. For ibuprofen, it was found that there were differences between the excipients that raised the solution pH above the pK(a) to those that did not. For the excipients raising the pH above the pK(a), the effect on intrinsic dissolution rate was not as high as that expected from the change in drug solubility. It was postulated that this might be due to lack of penetration of the excipient into the drug boundary layer microenvironment. Formulators may calculate the effect of adding an excipient based on solubility increases but may not find the dissolution rate improvement expected.


Assuntos
Acetaminofen/farmacocinética , Excipientes/química , Ibuprofeno/farmacocinética , Acetaminofen/química , Analgésicos não Narcóticos/química , Analgésicos não Narcóticos/farmacocinética , Bicarbonatos/química , Soluções Tampão , Implantes de Medicamento/química , Implantes de Medicamento/farmacocinética , Trato Gastrointestinal/fisiologia , Humanos , Concentração de Íons de Hidrogênio , Ibuprofeno/química , Lactose/química , Modelos Biológicos , Compostos de Potássio/química , Bicarbonato de Sódio/química , Cloreto de Sódio/química , Solubilidade , Tartaratos/química , Tecnologia Farmacêutica/métodos , Viscosidade , Água
4.
Int J Pharm ; 290(1-2): 145-54, 2005 Feb 16.
Artigo em Inglês | MEDLINE | ID: mdl-15664140

RESUMO

The aim of this study was to examine the diffusion of commonly administered analgesics, ibuprofen and paracetamol, through gastric mucus. As ibuprofen and paracetamol are often formulated with alkalising excipients, or are commonly co-administered with antacids that have been demonstrated to alter their absorption, diffusion was also studied in the presence of a range of soluble and insoluble antacids or buffering agents. The effect of pH, which has been demonstrated to modify the properties of mucus, was also studied. Mucus was a significant barrier to diffusion for both drugs, compared to an unstirred aqueous layer with diffusion rates significantly lower in the presence of a mucus barrier for both drugs; ibuprofen diffusion also demonstrated a significant increase in the lag time. Paracetamol diffusion was not significantly affected by addition of any antacid, whereas ibuprofen rates were affected and the diffusion lag time for ibuprofen was significantly reduced in all cases. Isolated increases in pH increased the rate and reduced the lag time for ibuprofen diffusion. It was shown that mucus acts as a passive barrier in the case of paracetamol diffusion, and an interactive barrier to ibuprofen diffusion. Changes in mucus viscosity at different pH values may be responsible for the observed changes in ibuprofen diffusion rate.


Assuntos
Acetaminofen/metabolismo , Excipientes/metabolismo , Mucosa Gástrica/metabolismo , Ibuprofeno/metabolismo , Muco/metabolismo , Acetaminofen/farmacologia , Animais , Excipientes/farmacologia , Ibuprofeno/farmacologia , Técnicas In Vitro , Muco/efeitos dos fármacos , Solubilidade/efeitos dos fármacos , Estômago/efeitos dos fármacos , Suínos
5.
Pharm Res ; 20(10): 1668-73, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14620524

RESUMO

PURPOSE: To investigate the hypothesis that faster drug absorption from a new paracetamol formulation containing sodium bicarbonate compared to that from a conventional formulation results from a combination of enhanced gastric emptying and disintegration/dissolution. METHODS: Each formulation was administered in both fasted and fed states to 12 healthy volunteers. Gastric emptying and disintegration times were assessed by gamma scintigraphy, and serum paracetamol concentrations were determined by HPLC. RESULTS: The mean time to complete disintegration of the new tablets was faster than that for conventional tablets in both fasted (10.2 min vs. 22.5 min) and fed (14.3 min vs. 46.4 min) states, although this difference was statistically significant in the fed state only (p = 0.0053). Mean gastric emptying times for the new tablets, as measured by t50 and t90, were also faster than those for conventional tablets in both fasted (t50 = 22.4 min vs. 47.5 min, t90 = 30.9 min vs. 64.1 min) and fed (t50 = 76.9 min vs. 106.4 min, t90 = 152.7 min vs. 155.5 min) states, although these differences were not statistically significant. Two subjects showed dramatically retarded gastric emptying of the new tablets in the fasted state: if these atypical data are excluded, the differences in both t50 and t90 in the fasted state are significant (p = 0.0110 and 0.0035, respectively). Rate of paracetamol absorption reflected the gastric emptying profiles as shown by significant correlation of emptying times with partial AUC. CONCLUSIONS: It would seem that a combination of faster disintegration and gastric emptying of the new tablets is responsible for the faster rate of absorption of paracetamol from PA compared to P observed in both this study and in previous studies. The differences in gastric emptying are more pronounced in the fasted state, and the differences in disintegration are more pronounced in the fed state.


Assuntos
Acetaminofen/química , Acetaminofen/farmacocinética , Esvaziamento Gástrico/efeitos dos fármacos , Administração Oral , Adulto , Química Farmacêutica , Cromatografia Líquida de Alta Pressão , Estudos Cross-Over , Excipientes , Feminino , Mucosa Gástrica/metabolismo , Humanos , Masculino , Cintilografia , Bicarbonato de Sódio , Solubilidade , Estômago/diagnóstico por imagem , Comprimidos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...